61.57
price up icon3.03%   1.81
after-market Handel nachbörslich: 61.53 -0.04 -0.06%
loading
Schlusskurs vom Vortag:
$59.76
Offen:
$60.32
24-Stunden-Volumen:
1.86M
Relative Volume:
1.54
Marktkapitalisierung:
$452.98M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-121.02M
KGV:
-5.468
EPS:
-11.26
Netto-Cashflow:
$-114.09M
1W Leistung:
+34.96%
1M Leistung:
+50.65%
6M Leistung:
+438.67%
1J Leistung:
+25.27%
1-Tages-Spanne:
Value
$58.61
$64.00
1-Wochen-Bereich:
Value
$42.12
$64.00
52-Wochen-Spanne:
Value
$7.31
$130.00

Tonix Pharmaceuticals Holding Corp Stock (TNXP) Company Profile

Name
Firmenname
Tonix Pharmaceuticals Holding Corp
Name
Telefon
212-980-9155
Name
Adresse
26 MAIN STREET, SUITE 101, CHATHAM, NY
Name
Mitarbeiter
81
Name
Twitter
@TONIXPharma
Name
Nächster Verdiensttermin
2025-03-17
Name
Neueste SEC-Einreichungen
Name
TNXP's Discussions on Twitter

Vergleichen Sie TNXP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TNXP
Tonix Pharmaceuticals Holding Corp
61.57 330.85M 0 -121.02M -114.09M -11.26
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.92 99.42B 11.42B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.55 58.99B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
432.52 56.35B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
646.60 39.02B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
307.51 34.25B 3.81B -644.79M -669.77M -6.24

Tonix Pharmaceuticals Holding Corp Stock (TNXP) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2022-04-18 Eingeleitet Noble Capital Markets Outperform
2019-04-18 Hochstufung ROTH Capital Neutral → Buy
2017-08-18 Hochstufung ROTH Capital Neutral → Buy
2016-09-07 Herabstufung ROTH Capital Buy → Neutral
2016-02-17 Bestätigt Oppenheimer Outperform
2015-11-04 Eingeleitet Cantor Fitzgerald Buy
2015-06-12 Eingeleitet Oppenheimer Outperform
2015-02-17 Bestätigt ROTH Capital Buy
2014-09-29 Bestätigt ROTH Capital Buy
Alle ansehen

Tonix Pharmaceuticals Holding Corp Aktie (TNXP) Neueste Nachrichten

pulisher
01:07 AM

Tonix Pharma: Eyes On FDA Deadline This Friday, I See A 65% Approval Potential (TNXP) - Seeking Alpha

01:07 AM
pulisher
10:09 AM

Tonix Pharmaceuticals Stock (TNXP) Opinions on Recent Price Surge - Quiver Quantitative

10:09 AM
pulisher
04:20 AM

Tonix Pharma Scores Best Day Since March On Hopes For First New Fibromyalgia Drug Approval in 16 Years; Retail’s Optimistic - Stocktwits

04:20 AM
pulisher
Aug 12, 2025

Tonix Pharmaceuticals Reports Q2 2025 EPS Loss of $3.86, Beating Estimates; Revenue Falls Short at $2.0 Million - GuruFocus

Aug 12, 2025
pulisher
Aug 12, 2025

TNXP Stock Surges: Analyzing Recent Performance - timothysykes.com

Aug 12, 2025
pulisher
Aug 12, 2025

Tonix Pharmaceuticals Confirms Cash Stability as Fibromyalgia Campaign Gains Traction - StocksToTrade

Aug 12, 2025
pulisher
Aug 12, 2025

Tonix Pharmaceuticals (TNXP) Stock Surges On Q2 Earnings Beat And Upcoming FDA Catalyst - Benzinga

Aug 12, 2025
pulisher
Aug 12, 2025

Tonix Pharmaceuticals’ Financial Future: Strong Indicators Signal Positive Outlook - timothysykes.com

Aug 12, 2025
pulisher
Aug 11, 2025

Tonix Pharmaceuticals Narrows Losses And Eyes New Drug Approval - Finimize

Aug 11, 2025
pulisher
Aug 11, 2025

Tonix Pharma earnings beat by $2.97, revenue fell short of estimates - Investing.com South Africa

Aug 11, 2025
pulisher
Aug 11, 2025

Tonix Pharmaceuticals reports Q2 net loss of $28.3 mln - MarketScreener

Aug 11, 2025
pulisher
Aug 11, 2025

Tonix Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Highlights - GlobeNewswire

Aug 11, 2025
pulisher
Aug 07, 2025

Top Biotech Penny Stocks to Watch Out for in August 2025 - StocksToTrade

Aug 07, 2025
pulisher
Aug 06, 2025

Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators - Benzinga

Aug 06, 2025
pulisher
Aug 04, 2025

Tonix Pharmaceuticals Innovation: What’s Next? - timothysykes.com

Aug 04, 2025
pulisher
Aug 04, 2025

TNXP’s Race Against Time: Market Buzz Remains High​ - StocksToTrade

Aug 04, 2025
pulisher
Aug 04, 2025

Tonix Pharmaceuticals Holding Corp. Added to Custom Quant Screener TodayMarket Entry and Exit Point Tips From Traders - metal.it

Aug 04, 2025
pulisher
Aug 04, 2025

Published on: 2025-08-04 09:31:49 - metal.it

Aug 04, 2025
pulisher
Aug 03, 2025

What institutional investors are buying Tonix Pharmaceuticals Holding Corp. stockInvest confidently with professional market insights - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Tonix Pharmaceuticals Holding Corp. compare to its industry peersOutstanding growth strategies - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

When is Tonix Pharmaceuticals Holding Corp. stock expected to show significant growthFree AI-Backed Trading Signals - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How strong is Tonix Pharmaceuticals Holding Corp. company’s balance sheetCapitalize on high-yield stocks early - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Should I hold or sell Tonix Pharmaceuticals Holding Corp. stock in 2025Phenomenal wealth increase - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

Is Tonix Pharmaceuticals Holding Corp. a growth stock or a value stockUnprecedented growth rates - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Published on: 2025-08-03 07:26:37 - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Does Tonix Pharmaceuticals Holding Corp. stock perform well during market downturnsDynamic profit opportunities - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

How volatile is Tonix Pharmaceuticals Holding Corp. stock compared to the marketUnlock high-yield investment opportunities - Jammu Links News

Aug 02, 2025
pulisher
Aug 01, 2025

Why is Tonix Pharmaceuticals Holding Corp. stock attracting strong analyst attentionWealth Building Opportunities For Beginners - Jammu Links News

Aug 01, 2025
pulisher
Aug 01, 2025

What are the technical indicators suggesting about Tonix Pharmaceuticals Holding Corp.Chart Pattern Report Backed By Experts - Jammu Links News

Aug 01, 2025
pulisher
Jul 30, 2025

Key resistance and support levels for Tonix Pharmaceuticals Holding Corp.Early Entry Picks Before News Breakout Reviewed - metal.it

Jul 30, 2025
pulisher
Jul 30, 2025

Tonix launches Move Fibro Forward campaign to support millions living with Fibromyalgia - Proactive financial news

Jul 30, 2025
pulisher
Jul 30, 2025

Price Channel Expanding on Tonix Pharmaceuticals Holding Corp.’s ChartLow Risk Swing Trade Opportunities Identified - metal.it

Jul 30, 2025
pulisher
Jul 29, 2025

TNXP: 2Q25 Financial Update and Deep Dive Into TNX-1500 - Smartkarma

Jul 29, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 17:18:40 - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

TNXP: 2Q25 Financial Update and Deep Dive Into TNX-1500… - Yahoo Finance

Jul 29, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 07:17:10 - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

What are Tonix Pharmaceuticals Holding Corp. company’s key revenue driversBreakthrough financial growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is the risk reward ratio of investing in Tonix Pharmaceuticals Holding Corp. stockDiscover high-impact stocks for your portfolio - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Is Tonix Pharmaceuticals Holding Corp. stock overvalued or undervaluedBuild a portfolio that outperforms consistently - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What makes Tonix Pharmaceuticals Holding Corp. stock price move sharplyHigh-return market picks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Why Tonix Pharmaceuticals Holding Corp. stock is on top investor watchlistsFree Market Dynamics Reports - metal.it

Jul 27, 2025

Finanzdaten der Tonix Pharmaceuticals Holding Corp-Aktie (TNXP)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$36.46
price up icon 1.67%
$85.85
price up icon 5.20%
$26.87
price up icon 4.61%
$122.87
price up icon 0.71%
$112.78
price up icon 1.60%
biotechnology ONC
$307.51
price up icon 6.74%
Kapitalisierung:     |  Volumen (24h):